We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.10 | 9.70 | 10.50 | 10.10 | 10.10 | 10.10 | 177,070 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.83 | 93.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2019 17:53 | I did post the question to scancell Bermuda ... if you dont read the posts how can you reply ? or is Clutter Lozan getting under your feet | inanaco | |
01/3/2019 17:48 | BoB - EXACTLY | the real lozan | |
01/3/2019 17:44 | Inanaco, Without you posting fully your question and the answer it's impossible to comment. My understanding is that the IND has not been approved, that there are O/S requirements that are in the hands of Ichor and that once Ichor have satisfied the FDA Scancell will have to go back and ask for the IND to be approved. On the funding side, they may have sufficient to commence the trial but they certainly don't have enough to complete it or start the Modi1 trial so funding will need to be sorted at some stage. | bermudashorts | |
01/3/2019 17:42 | only as Franz Beckenbauer who was a formidable sweeper even his wife gave him the broom ... clutter was not allowed | inanaco | |
01/3/2019 17:37 | YOU keep doing = GUFFAW Maybe folks don't need to respond... because, unlike YOU, folks are ABLE to see, and GET the point. that FUNDING CANnot be dismissed as an ISSUE | the real lozan | |
01/3/2019 17:28 | Lozan ... Clutter posting .. I repeat again .. nobody is responding to you | inanaco | |
01/3/2019 17:27 | No Bermuda what i am saying is the drug side of the FDA has clearly been sorted as i asked Scancell are we in a "clinical hold" and the reply came back NO ... we are held up by "medical device" so you cannot say that the SCIB1 "drug" is in a "clinical hold" as an issue scancell have stated its now FDA and Ichor ... its out of there control .... i did ask the very Specific question ..... "clinical hold" so cut me a bit of slack here if you cannot accept that ..maybe Cliff has it wrong ? | inanaco | |
01/3/2019 17:21 | Nappy, re my DIRECT question to YOU = "Nappy, Just to CLARIFY ...19978 "Funding is not an issue" ' Are YOU repeating YOUR last years FLAWED CLAIM of "FUNDING is NOT an ISSUE here" OR Are YOU dismissing / CLAIMING "Funding is not an issue" ... at, let's say - a couple of months / near future HERE ???" . Perhaps, due to YOUR difficulty in EVADING the issue/question, it would be beneficial for *US ALL* to presume YOUR dodgy 19978 "Funding IS not an ISSUE" is just ANOTHER example of YOUR misjudgement, leading to UNFOUNDED, FALSE CLAIMS made here.By YOU | the real lozan | |
01/3/2019 17:19 | Just to be clear, you are actually stating that the IND has been approved - you do realise that? | bermudashorts | |
01/3/2019 17:19 | Inanaco - I have missed that. When/where did they say they're not in a clinical hold? | bermudashorts | |
01/3/2019 17:07 | explain again Scancell just stated we are NOT in a clinical Hold ... | inanaco | |
01/3/2019 17:06 | BOOM ... scancell responded ... the 30 day has now passed LOL | inanaco | |
01/3/2019 17:00 | Well,,,YOU CAN'T | the real lozan | |
01/3/2019 16:59 | The CBER DID ASK QUESTIONS!!!!!!!! | bermudashorts | |
01/3/2019 16:57 | Lozan ... stop cluttering up a good thread ... nobody is interested in your funding posts ... nobody ever replies to them | inanaco | |
01/3/2019 16:56 | so that refers to the actual question i asked Scancell I am getting a bit confused with the Status of The Combination trial and the FDA, are we in a state of "clinical hold" or are these questions asked by the FDA informal ? I appreciate you have indicated that all the questions have been answered as per your proactive investor interview, but looking at the FDA procedural policy, 30 day turn rounds for a response is policy ... so I am not quite sure which rules are in play reply was "medical devices" NOT "clinical hold" | inanaco | |
01/3/2019 16:56 | "Funding was not an issue lozan .... funding has been raised " .... SO = FUNDING WAS in FACT, an ISSUE...When YOU CLAIMED "It was NOT" That same Funding YOU now CLAIM = " funding has been raised " 10 MONTHS AGO . Are YOU CLAIMING - FUNDING WAS NOT an ISSUE here 10 MONTHS AGO OR Are YOU dismissing / CLAIMING "Funding is not an issue" ...in/ at, let's say - a couple of months / near future HERE ??? OR ...Both ??? Bearing in mind, YOU have been KNOWN to have been PROVEN WRONG in the past. | the real lozan | |
01/3/2019 16:53 | Bermuda "have been compiled " past tense ... time scales ... which is why I looked at the 30 day .... now i look at H1 2019 nothing has changed Actually you don't have to ask for approval of the IND its automatic after 30 days if they don't respond ... as it seems that is centered around the medical device then the IND is NOT on a clinical hold otherwise that section ie the "drug FDA" would also have asked questions Review Time for initial submission of an Investigational New Drug application is 30 days from the date FDA receives the IND. An IND applicant may proceed with a clinical investigation once the applicant has been notified by FDA that the investigation may proceed or after 30 days if the IND is not placed on Clinical Hold. | inanaco | |
01/3/2019 16:43 | Inanaco, I'm sorry but I just don't accept that we've been told Scancell have submitted all O/S requirements. I can understand why you may think this as you're going by CH's comments on the proactive interview on 23rd Jan. I found the actual words used very difficult to hear and remember some debate about it at the time. Did he say answers to questions 'have been' compiled or 'are being' compiled? I just don't know. Either way, it's sort of irrelevant because a week after that interview this is the situation according to an RNS:- 'Scancell and Ichor continue to work with the FDA to provide the additional information requested in response to the Investigational New Drug application submitted for the SCIB1 Phase 2 checkpoint inhibitor combination study' You're right when you say that it's now between Ichor and the FDA and Scancell have no control over that but my point was that once that is sorted Scancell will then have to ask the FDA (CBER) to approve the IND. ie. They do have to go back to the FDA when Ichor have submitted all O/S requirements. Regarding the last sentence of your 20045 - it hadn't even crossed my mind that the FDA would refuse, if you think that's what I'm getting at then you're very much mistaken. All I'm trying to do is understand the process to make some sense of the timescales here and manage expectations. Much better to try to understand why it may be taking so long IMO. | bermudashorts | |
01/3/2019 16:41 | Funding was not an issue lozan .... funding has been raised | inanaco | |
01/3/2019 16:39 | " "PHD" ... level staff are replying to questions asked ..." . Unlike YOU, who won't / CAN't reply to "questions asked ..as per = Nappy, re my DIRECT question to YOU = "Nappy, Just to CLARIFY ...19978 "Funding is not an issue" ' Are YOU repeating YOUR last years FLAWED CLAIM of "FUNDING is NOT an ISSUE here" OR Are YOU dismissing / CLAIMING "Funding is not an issue" ... at, let's say - a couple of months / near future HERE ???" . *WE ALL* CAN clearly see and understand YOUR 'reluctance' to respond / Answer the question. After all, Would anyone want to make a CLAIM... that subsequently was PROVEN to have been TOTALLY WRONG ??? Should FUNDING, in the 'not too distant', actually become 'an issue'... or a REALITY | the real lozan | |
01/3/2019 16:23 | ONE thing that i do know ONW "PHD" ... level staff are replying to questions asked ... Not TOSH/lozan/or ONW ... | inanaco | |
01/3/2019 16:19 | Bermuda Yep, a bit like saying we're planning for H1 2019! I'm sure you realise where I'm coming from in all this, and it's not saying that the IND's really not likely to be granted (I hope)! I guess the great issue here is that the FDA can keep on asking for more details (and I believe different panels can actually demand greater detail than others), so there's simply no benchmark from which to work. I may be wrong on this, so please give me a little leeway, I'm no expert. But that's part of the problem, noone here is, so we have to give and take a bit and judge for ourselves who (if anyone) has the monopoly of information. It's not a straightforward situation, and there's certainly more to all of this than we (probably) really know. In the meantime an update would be helpful, but what to say? "We've sent it all in and awaiting response whilst planning for a start to the trial in H1 2019" Oh yes, that's what CH said today.... What else can he say??? Answers on a BB to .... Hehe Anyway thanks for your input... really is appreciated. AIMO ATB | oldnotwise | |
01/3/2019 16:16 | Boom Scancell have already stated its now between Ichor and the FDA ... and they have stated that "those questions from the FDA have been responded to" which included Ichor ... listen to the proactive anyway .. no point discussing unicorns when you have no evidence that the FDA will refuse | inanaco | |
01/3/2019 16:12 | No ... i don't need to re think ... ONW as you have no evidence from the FDA to say that they will NOT approve as such you cannot challenge any part of the post .. because Tri Grid 2 has already been approved in Europe ... Scancell has stated all the answers to questions have been compiled and sent to the FDA so your evidence to support failure is only based on conjecture created by yourself not fact | inanaco |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions